HTR4 and Alzheimer disease: Activation of 5HT4, 5HT6, and 5HT7 receptors in experimental models of AD resulted in a decrease in Aβ content [44,45,46,47], while injections of Aβ in the hippocampi of mouse models of AD [48,49] leads to a reduction in 5HT2A receptor expression.